119 related articles for article (PubMed ID: 15537085)
1. Ancient weapons for attack and defense: the pore-forming polypeptides of pathogenic enteric and free-living amoeboid protozoa.
Leippe M; Herbst R
J Eukaryot Microbiol; 2004; 51(5):516-21. PubMed ID: 15537085
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial and cytolytic polypeptides of amoeboid protozoa--effector molecules of primitive phagocytes.
Leippe M
Dev Comp Immunol; 1999; 23(4-5):267-79. PubMed ID: 10426421
[TBL] [Abstract][Full Text] [Related]
3. Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.
Herbst R; Ott C; Jacobs T; Marti T; Marciano-Cabral F; Leippe M
J Biol Chem; 2002 Jun; 277(25):22353-60. PubMed ID: 11948186
[TBL] [Abstract][Full Text] [Related]
4. Amoebapores, archaic effector peptides of protozoan origin, are discharged into phagosomes and kill bacteria by permeabilizing their membranes.
Andrä J; Herbst R; Leippe M
Dev Comp Immunol; 2003 Apr; 27(4):291-304. PubMed ID: 12590963
[TBL] [Abstract][Full Text] [Related]
5. Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.
Leippe M; Andrä J; Nickel R; Tannich E; Müller-Eberhard HJ
Mol Microbiol; 1994 Dec; 14(5):895-904. PubMed ID: 7715451
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial and pore-forming peptides of free-living and potentially highly pathogenic Naegleria fowleri are released from the same precursor molecule.
Herbst R; Marciano-Cabral F; Leippe M
J Biol Chem; 2004 Jun; 279(25):25955-8. PubMed ID: 15075336
[TBL] [Abstract][Full Text] [Related]
7. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity.
Nickel R; Ott C; Dandekar T; Leippe M
Eur J Biochem; 1999 Nov; 265(3):1002-7. PubMed ID: 10518795
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence.
Bracha R; Nuchamowitz Y; Leippe M; Mirelman D
Mol Microbiol; 1999 Nov; 34(3):463-72. PubMed ID: 10564488
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica.
Leippe M; Sievertsen HJ; Tannich E; Horstmann RD
Parasitology; 1995 Dec; 111 ( Pt 5)():569-74. PubMed ID: 8559589
[TBL] [Abstract][Full Text] [Related]
10. Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis.
Bruhn H; Riekens B; Berninghausen O; Leippe M
Biochem J; 2003 Nov; 375(Pt 3):737-44. PubMed ID: 12917014
[TBL] [Abstract][Full Text] [Related]
11. Ancient weapons: the three-dimensional structure of amoebapore A.
Leippe M; Bruhn H; Hecht O; Grötzinger J
Trends Parasitol; 2005 Jan; 21(1):5-7. PubMed ID: 15639732
[TBL] [Abstract][Full Text] [Related]
12. The pore-forming peptide of Entamoeba histolytica, the protozoan parasite causing human amoebiasis.
Leippe M; Müller-Eberhard HJ
Toxicology; 1994 Feb; 87(1-3):5-18. PubMed ID: 7512763
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.
Leippe M; Andrä J; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2602-6. PubMed ID: 8146160
[TBL] [Abstract][Full Text] [Related]
14. Cell-free synthesis and combinatorial selective 15N-labeling of the cytotoxic protein amoebapore A from Entamoeba histolytica.
Xun Y; Tremouilhac P; Carraher C; Gelhaus C; Ozawa K; Otting G; Dixon NE; Leippe M; Grötzinger J; Dingley AJ; Kralicek AV
Protein Expr Purif; 2009 Nov; 68(1):22-7. PubMed ID: 19573603
[TBL] [Abstract][Full Text] [Related]
15. Membrane lipid composition protects Entamoeba histolytica from self-destruction by its pore-forming toxins.
Andrä J; Berninghausen O; Leippe M
FEBS Lett; 2004 Apr; 564(1-2):109-15. PubMed ID: 15094050
[TBL] [Abstract][Full Text] [Related]
16. Novel putative saposin-like proteins of Entamoeba histolytica different from amoebapores.
Bruhn H; Leippe M
Biochim Biophys Acta; 2001 Sep; 1514(1):14-20. PubMed ID: 11513801
[TBL] [Abstract][Full Text] [Related]
17. A novel saposin-like protein of Entamoeba histolytica with membrane-fusogenic activity.
Winkelmann J; Leippe M; Bruhn H
Mol Biochem Parasitol; 2006 May; 147(1):85-94. PubMed ID: 16529828
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of the pore-forming protein of Entamoeba histolytica.
Hecht O; Van Nuland NA; Schleinkofer K; Dingley AJ; Bruhn H; Leippe M; Grötzinger J
J Biol Chem; 2004 Apr; 279(17):17834-41. PubMed ID: 14970207
[TBL] [Abstract][Full Text] [Related]
19. Shortened amoebapore analogs with enhanced antibacterial and cytolytic activity.
Andrä J; Berninghausen O; Wülfken J; Leippe M
FEBS Lett; 1996 Apr; 385(1-2):96-100. PubMed ID: 8641476
[TBL] [Abstract][Full Text] [Related]
20. Drug targets from human pathogenic amoebas: Entamoeba histolytica, Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN
Infect Disord Drug Targets; 2007 Sep; 7(3):266-80. PubMed ID: 17897063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
